Cited by 1,030Genetic Neurodegenerative DiseasesMitochondrial Function and PathologyHereditary Neurological Disorders

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines

Panov, Alexander V., Gutekunst, Claire-Anne, Leavitt, Blair R., Hayden, Michael R., Burke, James R., Strittmatter, Warren J., Greenamyre, J. Timothy·2002·Nature Neuroscience

DOI 10.1038/nn884

Open this paper in CoChat — free account

Abstract

Huntington's disease (HD) is caused by an expansion of exonic CAG triplet repeats in the gene encoding huntingtin protein (Htt), but the mechanisms by which this mutant protein causes neurodegeneration remain unknown. Here we show that lymphoblast mitochondria from patients with HD have a lower membrane potential and depolarize at lower calcium loads than do mitochondria from controls. We found a similar defect in brain mitochondria from transgenic mice expressing full-length mutant huntingtin, and this defect preceded the onset of pathological or behavioral abnormalities by months. By electron microscopy, we identified N-terminal mutant huntingtin on neuronal mitochondrial membranes, and by incubating normal mitochondria with a fusion protein containing an abnormally long polyglutamine repeat, we reproduced the mitochondrial calcium defect seen in human patients and transgenic animals. Thus, mitochondrial calcium abnormalities occur early in HD pathogenesis and may be a direct effect of mutant huntingtin on the organelle.

Integrity signals

Registry

Crossref · 10.1038/nn884

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R. S., Sherer, T., MacKenzie, G. M., Garcia‐Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,770
Self-citation
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439
Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation
Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,188
Mitochondrial Transport of Cations: Channels, Exchangers, and Permeability Transition
Bernardi, P. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1127 · Cited by 1,546
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,434
Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo
Scherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G. P., Davies, S. W., Lehrach, H., & Wanker, E. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80514-0 · Cited by 1,291 · cited 1×
“Consistent with the toxic 'gain-of-function' hypothesis, mutant Htt self-associates and forms aggregates in a polyglutamine length–dependent manne”
Background
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
Steffan, J. S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B. L., Kazantsev, A., Schmidt, E., Zhu, Y.-Z., Greenwald, M., et al. (2001) · Nature · doi:10.1038/35099568 · Cited by 1,228
Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease
Zuccato, C., Ciammola, A., Rigamonti, D., Leavitt, B. R., Goffredo, D., Conti, L., MacDonald, M. E., Friedlander, R. M., Silani, V., Hayden, M. R., et al. (2001) · Science · doi:10.1126/science.1059581 · Cited by 1,123
Self-citation

Show all 35 references

Sorted by citations

Items 401–500 of 1,000

Mitochondrial function and dynamics in neural stem cells and neurogenesis: Implications for neurodegenerative diseases
Coelho, P., Fão, L., Mota, S. I., & Rego, A. C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101667 · Cited by 62
Intracellular zinc is a critical intermediate in the excitotoxic cascade
Granzotto, A., & Sensi, S. L. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.010 · Cited by 59
Mouse Models of Polyglutamine Diseases: Review and Data Table. Part I
Figiel, M., Szlachcic, W. J., Switonski, P. M., Gabka, A., & Krzyżosiak, W. J. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8315-4 · Cited by 60
Calcium dysregulation, functional calpainopathy, and endoplasmic reticulum stress in sporadic inclusion body myositis
Amici, D. R., Pinal‐Fernandez, I., Mázala, D. A. G., Lloyd, T. E., Corse, A. M., Christopher‐Stine, L., Mammen, A. L., & Chin, E. R. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0427-7 · Cited by 57
Channels formed with a mutant prion protein PrP(82-146) homologous to a 7-kDa fragment in diseased brain of GSS patients
Bahadi, R., Farrelly, P. V., Kenna, B. L., Kourie, J. I., Tagliavini, F., Forloni, G., & Salmona, M. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00077.2003 · Cited by 56
The Neuroprotective Role of Creatine
Klein, A., & Ferrante, R. J. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6486-9_11 · Cited by 56
Role for calcium signaling in manganese neurotoxicity
Ijomone, O. M., Aluko, O. M., Okoh, C. O. A., Martins, A. C., & Aschner, M. (2019) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2019.08.006 · Cited by 58
Induction of hypoxia inducible factor‐1 attenuates metabolic insults induced by 3‐nitropropionic acid in rat C6 glioma cells
Yang, Y., Ju, T., & Yang, D. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03032.x · Cited by 56
Mitochondrial-dependent apoptosis in Huntington's disease human cybrids
Ferreira, I. L., Nascimento, M. V., Ribeiro, M., Almeida, S., Cardoso, S. M., Grazina, M. M., Pratas, J., Santos, M. J., Januário, C., Oliveira, C. R., et al. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.01.002 · Cited by 56
Primary cilia and autophagic dysfunction in Huntington’s disease
Kaliszewski, M., Knott, A. B., & Bossy-Wetzel, E. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2015.80 · Cited by 55
Axonopathy in Huntington's disease
Li, J.-Y., & Conforti, L. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.08.010 · Cited by 55
Metabolic Disturbances in Diseases with Neurological Involvement
Duarte, J. M. N. (2014) · Aging and Disease · doi:10.14336/ad.2014.0500238 · Cited by 55
Neuronal Ca2+dyshomeostasis in Huntington disease
Giacomello, M., Oliveros, J. C., Naranjo, J. R., & Carafoli, E. (2013) · Prion · doi:10.4161/pri.23581 · Cited by 58
Dysregulation of Neuronal Calcium Signaling via Store-Operated Channels in Huntington's Disease
Czeredys, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.611735 · Cited by 56
Evaluation of clinically relevant glutamate pathway inhibitors in in vitro model of Huntington's disease
Wu, J., Tang, T.-S., & Борисович, Б. И. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.08.036 · Cited by 55
Stem cell‐based cell therapy for Huntington disease: A review
Kim, M., Lee, S., Chu, K., & Kim, S. U. (2007) · Neuropathology · doi:10.1111/j.1440-1789.2007.00858.x · Cited by 54
Role of tissue transglutaminase-2 (TG2)-mediated aminylation in biological processes
Lai, T., Lin, C., & Greenberg, C. S. (2016) · Amino Acids · doi:10.1007/s00726-016-2270-8 · Cited by 55
Mutant Huntingtin and Elusive Defects in Oxidative Metabolism and Mitochondrial Calcium Handling
Brustovetsky, N. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9188-0 · Cited by 54
Polyglutamine gene function and dysfunction in the ageing brain
Hands, S. L., Sinadinos, C., & Wyttenbach, A. (2008) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2008.05.008 · Cited by 55
Death of cortical and striatal neurons induced by mitochondrial defect involves differential molecular mechanisms
Galas, M., Bizat, N., Cuvelier, L., Bantubungi, K., Brouillet, E., Schiffmann, S. N., & Blum, D. L. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.013 · Cited by 54
Identification of a presymptomatic molecular phenotype in Hdh CAG knock-in mice
Fossale, E. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.19.2233 · Cited by 54
Bax‐like protein Drob‐1 protects neurons from expanded polyglutamine‐induced toxicity in Drosophila
Senoo‐Matsuda, N., Igaki, T., & Miura, M. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600721 · Cited by 57
Mitochondrial Membrane Fluidity is Consistently Increased in Different Models of Huntington Disease: Restorative Effects of Olesoxime
Eckmann, J., Clemens, L. E., Eckert, S. H., Hagl, S., Yu-Taeger, L., Bordet, T., Pruss, R. M., Muller, W. E., Leuner, K., Nguyen, H. P., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8663-3 · Cited by 56
Increased nuclear DNA damage precedes mitochondrial dysfunction in peripheral blood mononuclear cells from Huntington’s disease patients
Askeland, G., Dosoudilova, Z., Rodinová, M., Klempíř, J., Lišková, I., Kuśnierczyk, A., Bjørås, M., Nesse, G., Klungland, A., Hansíková, H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27985-y · Cited by 53
Biological Aging and the Cellular Pathogenesis of Huntington’s Disease
Machiela, E., & Southwell, A. L. (2020) · Journal of Huntington s Disease · doi:10.3233/jhd-200395 · Cited by 54
Huntington’s Disease
Roze, E. F., Bonnet, C., Bétuing, S., & Caboche, J. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6448-9_5 · Cited by 54
Minocycline in phenotypic models of Huntington's disease
Bantubungi, K., Jacquard, C., Greco, A., Pintor, A., Chtarto, A., Taï, K., Galas, M., Tenenbaum, L., Déglon, N., Popoli, P., et al. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.017 · Cited by 53
Striatal specificity of gene expression dysregulation in Huntington's disease
Thomas, E. A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21046 · Cited by 53
Extended polyglutamine repeats trigger a feedback loop involving the mitochondrial complex III, the proteasome and huntingtin aggregates
Fukui, H., & Moraes, C. T. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm023 · Cited by 57
Korean Red Ginseng Extract Attenuates 3-Nitropropionic Acid-Induced Huntington’s-Like Symptoms
Jang, M., Lee, M. J., Kim, C. S., & Cho, I. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/237207 · Cited by 52
Neurodegenerative Disorders
Yacoubian, T. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802810-0.00001-5 · Cited by 56
Dysfunction of Mitochondrial Ca2+ Regulatory Machineries in Brain Aging and Neurodegenerative Diseases
Jung, H., Kim, S. Y., Cecen, F. S. C., Cho, Y., & Kwon, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.599792 · Cited by 56
Sirtuins: double players in Huntington's disease
Naia, L., & Rego, A. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.07.003 · Cited by 54
Pathogenic Mechanisms in Huntington's Disease
Jones, L., & Hughes, A. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-381328-2.00015-8 · Cited by 51
Ca2+ handling in isolated brain mitochondria and cultured neurons derived from the YAC 128 mouse model of Huntington's disease
Pellman, J. J., Hamilton, J., Brustovetsky, T., & Brustovetsky, N. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13165 · Cited by 51
Age‐related changes in regional brain mitochondria from Fischer 344 rats
LaFrance, R., Brustovetsky, N., Sherburne, C., DeLong, D., & Dubinsky, J. M. (2005) · Aging Cell · doi:10.1111/j.1474-9726.2005.00156.x · Cited by 51
Targeting Neuro-Inflammatory Cytokines and Oxidative Stress by Minocycline Attenuates Quinolinic-Acid-Induced Huntington’s Disease-Like Symptoms in Rats
Kalonia, H., Mishra, J., & Kumar, A. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9315-x · Cited by 51
Recent Advances in Hereditary Spinocerebellar Ataxias
van de Warrenburg, B. P. C., Sinke, R. J., & Kremer, B. P. H. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.3.171 · Cited by 52
Depletion of mitochondrial DNA in leukocytes of patients with poly-Q diseases
Liu, C., Cheng, W., Kuo, S., Li, J., Soong, B., & Wei, Y. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.07.016 · Cited by 52
Experimental therapeutics in Huntington's disease
Bates, G. P., & Hockly, E. (2003) · Current Opinion in Neurology · doi:10.1097/01.wco.0000084223.82329.bb · Cited by 51
Both Orai1 and TRPC1 are Involved in Excessive Store-Operated Calcium Entry in Striatal Neurons Expressing Mutant Huntingtin Exon 1
Vigont, V. A., Kostritskaia, Y., Skopin, A. Y., Zimina, O. A., Zenin, V. V., Глушанкова, Л. Н., & Kaznacheyeva, E. V. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00337 · Cited by 50
Bioenergetic medicine
Swerdlow, R. H. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12394 · Cited by 51
Striatal hypometabolism in premanifest and manifest Huntington’s disease patients
López-Mora, D. A., Camacho, V., Pérez‐Pérez, J., Martínez‐Horta, S., Fernández‐León, A., Sampedro, F., Montes, A., Lozano‐Martinez, G. A., Gómez‐Ansón, B., Kulisevsky, J., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3445-y · Cited by 50
Apoptosis-Inducing Factor Deficiency Induces Early Mitochondrial Degeneration in Brain Followed by Progressive Multifocal Neuropathology
Ghouzzi, V. E., Csaba, Z., Olivier, P., Lelouvier, B., Schwendimann, L., Dournaud, P., Verney, C., Rustin, P., & Gressèns, P. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318148b822 · Cited by 53
Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration
Tenchov, R., Sasso, J. M., & Zhou, Q. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00184 · Cited by 53
Calcium-mediated regulation of mitophagy: implications in neurodegenerative diseases
Borbolis, F., Ploumi, C., & Palikaras, K. (2025) · npj Metabolic Health and Disease · doi:10.1038/s44324-025-00049-2 · Cited by 50
Melatonin protects against behavioural dysfunctions and dendritic spine damage in 3-nitropropionic acid-induced rat model of Huntington's disease
Chakraborty, J., Nthenge-Ngumbau, D. N., Rajamma, U., & Mohanakumar, K. P. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.01.048 · Cited by 49
The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders
Wong, B. X. W., & Duce, J. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00081 · Cited by 50
Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: Possible role of peroxisome proliferator activated receptor-ϒ (PPARϒ) in Huntington's disease
Kalonia, H., Kumar, P., & Kumar, A. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.04.018 · Cited by 49
Mitochondrial alterations accompanied by oxidative stress conditions in skin fibroblasts of Huntington’s disease patients
Jędrak, P., Mozolewski, P., Węgrzyn, G., & Wieckowski, M. R. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0308-1 · Cited by 49
Rhes, a striatal-enriched protein, promotes mitophagy via Nix
Sharma, M., Ramírez-Jarquín, U. N., Rivera, O., Kazantzis, M., Eshraghi, M., Shahani, N., Sharma, V., Tapia, R., & Subramaniam, S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912868116 · Cited by 49
Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor
Mandrusiak, L. M. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg161 · Cited by 49
Cysteine String Protein (CSP) Inhibition of N-type Calcium Channels Is Blocked by Mutant Huntingtin
Miller, L. C., Swayne, L. A., Chen, L., Feng, Z., Wacker, J. L., Muchowski, P. J., Zamponi, G. W., & Braun, J. E. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306230200 · Cited by 49
Huntington’s Disease: Calcium Dyshomeostasis and Pathology Models
Kolobkova, Y. A., Vigont, V. A., Shalygin, A. V., & Kaznacheyeva, E. V. (2017) · Acta Naturae · doi:10.32607/20758251-2017-9-2-34-46 · Cited by 51
Mechanisms of neuronal cell death in Huntington’s disease
Sawa, A., Tomoda, T., & Bae, B.-I. (2003) · Cytogenetic and Genome Research · doi:10.1159/000072864 · Cited by 48
Caenorhabditis elegans as a model system to study intercompartmental proteostasis: Interrelation of mitochondrial function, longevity, and neurodegenerative diseases
Kirstein, J., & Morimoto, R. I. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22292 · Cited by 52
Huntington's disease, calcium, and mitochondria
Giacomello, M., Hudec, R., & Lopreiato, R. (2011) · BioFactors · doi:10.1002/biof.162 · Cited by 49
Mitochondrial respiratory chain complex activity and bioenergetic alterations in human platelets derived from pre-symptomatic and symptomatic Huntington's disease carriers
da Silva, A. B. G., Almeida, S., Laço, M., Duarte, A. I., Domingues, J., Oliveira, C. R., Januário, C., & Rego, A. C. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.05.006 · Cited by 47
Compromised mitochondrial complex II in models of Machado–Joseph disease
Laço, M., Oliveira, C. R., Paulson, H. L., & Rego, A. C. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.010 · Cited by 47
Suppression of polyglutamine‐induced cytotoxicity in Saccharomyces cerevisiae by enhancement of mitochondrial biogenesis
Ocampo, A., Zambrano, A., & Barrientos, A. (2009) · The FASEB Journal · doi:10.1096/fj.09-148601 · Cited by 47
Protein oxidation in Huntington disease
Sorolla, M. A., Colman, M. J. R., Vall‐llaura, N., Tamarit, J., Ros, J., & Cabiscol, E. (2012) · BioFactors · doi:10.1002/biof.1013 · Cited by 48
Forkhead Transcription Factor FOXO3a Levels Are Increased in Huntington Disease Because of Overactivated Positive Autofeedback Loop
Kannike, K., Sepp, M., Zuccato, C., Cattaneo, E. F., & Timmusk, T. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.612424 · Cited by 49
Crosstalk between huntingtin and syntaxin 1A regulates N-type calcium channels
Swayne, L. A., Chen, L., Hameed, S., Barr, W., Charlesworth, E., Colicos, M. A., Zamponi, G. W., & Braun, J. E. A. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.07.016 · Cited by 47
Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease
Kim, J., Amante, D. J., Moody, J. P., Edgerly, C. K., Bordiuk, O. L., Smith, K., Matson, S. A., Matson, W. R., Scherzer, C. R., Rosas, H. D., et al. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.05.001 · Cited by 47
New Insights into Mitochondria in Health and Diseases
Li, Y., Zhang, H., Yu, C., Dong, X., Yang, F., Wang, M., Wen, Z., Su, M., Li, B., & Yang, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189975 · Cited by 48
Mitochondrial Ca2+ handling in Huntington's and Alzheimer's diseases – Role of ER-mitochondria crosstalk
Naia, L., Ferreira, I. L., Ferreiro, E. B., & Rego, A. C. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.07.122 · Cited by 49
Mediators of mitophagy that regulate mitochondrial quality control play crucial role in diverse pathophysiology
De, R., Mazumder, S., & Bandyopadhyay, U. (2020) · Cell Biology and Toxicology · doi:10.1007/s10565-020-09561-1 · Cited by 47
Splitting up the powerhouse: structural insights into the mechanism of mitochondrial fission
Richter, V., Singh, A. P., Kvansakul, M., Ryan, M. T., & Osellame, L. D. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1950-y · Cited by 48
Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington's Disease
Goffredo, D., Rigamonti, D., Zuccato, C., Tartari, M., Valenza, M., & Cattaneo, E. F. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.01.006 · Cited by 46
Mitochondrial Aconitase is a Transglutaminase 2 Substrate: Transglutamination is a Probable Mechanism Contributing to High-Molecular-Weight Aggregates of Aconitase and Loss of Aconitase Activity in Huntington Disease Brain
Kim, S., Marekov, L. N., Bubber, P., Browne, S. E., Stavrovskaya, I. G., Lee, J., Steinert, P. M., Blass, J. P., Beal, M. F., Gibson, G. E., et al. (2005) · Neurochemical Research · doi:10.1007/s11064-005-8796-x · Cited by 46
Different phenotypic expression in monozygotic twins with Huntington disease
Anca‐Herschkovitsch, M., Gazit, E., Loewenthal, R., Ostrovsky, O., Frydman, M., & Giladi, N. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20328 · Cited by 46
The Mitochondrial Permeability Transition as a Target for Neuroprotection
Kristal, B. S., Stavrovskaya, I. G., Narayanan, M. V., Krasnikov, B. F., Brown, A. M., Beal, M. F., & Friedlander, R. M. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041759.35731.70 · Cited by 46
Huntington’s Disease and Group I Metabotropic Glutamate Receptors
Ribeiro, F. M., Pires, R. G. W., & Ferguson, S. S. G. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8153-1 · Cited by 50
Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain
Lim, N. K.-H., Hung, L. W., Pang, T. Y., McLean, C., Liddell, J. R., Hilton, J. B. W., Li, Q.-X., White, A. R., Hannan, A. J., & Crouch, P. J. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu119 · Cited by 45
Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat
Clemens, L. E., Weber, J. J., Wlodkowski, T., Yu-Taeger, L., Michaud, M., Calaminus, C., Eckert, S. H., Gaca, J., Weiss, A., Magg, J. C. D., et al. (2015) · Brain · doi:10.1093/brain/awv290 · Cited by 47
The Role of Adenosine Tone and Adenosine Receptors in Huntington's Disease
Blum, D. L., Chern, Y., Domenici, M. R., Buée, L., Lin, C., Rea, W. P., Ferré, S., & Popoli, P. (2018) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2018.0006 · Cited by 48
Inositol 1,4,5-tripshosphate receptor, calcium signalling and huntington’s disease
Борисович, Б. И. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6191-2_11 · Cited by 45
Neuroanatomical distribution of huntingtin‐associated protein 1‐mRNA in the male mouse brain
Fujinaga, R., Kawano, J., Matsuzaki, Y., Kamei, K., Yanai, A., Sheng, Z., Tanaka, M., Nakahama, K., Nagano, M., & Shinoda, K. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20277 · Cited by 47
Mitochondrial dysfunction in cellular senescence: a bridge to neurodegenerative disease
Hruby, A. J., & Higuchi‐Sanabria, R. (2025) · npj Aging · doi:10.1038/s41514-025-00291-4 · Cited by 52
Mitochondrial bioenergetics and dynamics in Huntington’s disease: tripartite synapses and selective striatal degeneration
Oliveira, J. M. A. (2010) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-010-9287-6 · Cited by 44
Mitochondrial matters of the brain: the role in Huntington’s disease
Turner, C., & Schapira, A. H. V. (2010) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-010-9290-y · Cited by 45
To live or to die: a matter of processing damaged DNA termini in neurons
El‐Khamisy, S. F. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201000114 · Cited by 44
Adenosine Receptors and Huntington's Disease
Lee, C.-F., & Chern, Y. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00010-6 · Cited by 44
STIM2 Mediates Excessive Store-Operated Calcium Entry in Patient-Specific iPSC-Derived Neurons Modeling a Juvenile Form of Huntington's Disease
Vigont, V. A., Grekhnev, D. A., Lebedeva, O. S., Gusev, K. O., Volovikov, E. A., Skopin, A. Y., Bogomazova, A. N., Belikova, L. D., Zubkova, O. A., Khomyakova, E. A., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.625231 · Cited by 44
Mitochondrial medicine and the neurodegenerative mitochondriopathies
Swerdlow, R. H. (2009) · Pharmaceuticals · doi:10.3390/ph2030150 · Cited by 43
Huntington's Disease and its therapeutic target genes: a global functional profile based on the HD Research Crossroads database
Kalathur, R. K. R., Hernández‐Prieto, M. A., & Futschik, M. E. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-47 · Cited by 46
VCP cooperates with UBXD1 to degrade mitochondrial outer membrane protein MCL1 in model of Huntington's disease
Guo, X. L., & Qi, X. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.026 · Cited by 43
Polyglutamine expansion inhibits respiration by increasing reactive oxygen species in isolated mitochondria
Puranam, K. L., Wu, G., Strittmatter, W. J., & Burke, J. R. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.007 · Cited by 44
Self-citation
Amelioration of Huntington's disease phenotypes by Beta-Lapachone is associated with increases in Sirt1 expression, CREB phosphorylation and PGC-1α deacetylation
Lee, M., Ban, J.-J., Chung, J. Y., Im, W., & Kim, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195968 · Cited by 42
Mitochondrial Bioenergy in Neurodegenerative Disease: Huntington and Parkinson
Tassone, A., Meringolo, M., Ponterio, G., Bonsi, P., Schirinzi, T., & Martella, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087221 · Cited by 42
Metabolism in HD: Still a relevant mechanism?
Duan, W., Jiang, M., & Jin, J. (2014) · Movement Disorders · doi:10.1002/mds.25992 · Cited by 41
The dysfunction of hepatic transcriptional factors in mice with Huntington's Disease
Chiang, M., Chern, Y., & Juo, C. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.05.006 · Cited by 41
Brain activity regulates loose coupling between mitochondrial and cytosolic Ca2+ transients
Lin, Y., Li, L., Nie, W., Liu, X., Adler, A., Xiao, C., Lu, F., Wang, L., Han, H., Wang, X., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13142-0 · Cited by 44
Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington’s Disease
D’Egidio, F., Castelli, V., Cimini, A., & d’Angelo, M. (2023) · Antioxidants · doi:10.3390/antiox12030571 · Cited by 42
SPG20 Protein Spartin Associates with Cardiolipin via Its Plant-Related Senescence Domain and Regulates Mitochondrial Ca2+ Homeostasis
Joshi, D. C., & Bakowska, J. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019290 · Cited by 41
Erythropoietin and sonic hedgehog mediate the neuroprotective effects of brain-derived neurotrophic factor against mitochondrial inhibition
Wu, C., Chen, S., Yin, J., Hwang, C., & Yang, D. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.019 · Cited by 41
Abnormal Ca2+Dynamics in Transgenic Mice with Neuron-Specific Mitochondrial DNA Defects
Kubota, M., Kasahara, T., Nakamura, T., Ishiwata, M., Miyauchi, T., & Kato, T. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3933-06.2006 · Cited by 41
Membrane Pores in the Pathogenesis of Neurodegenerative Disease
Kagan, B. L. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00001-1 · Cited by 44
Cause or compensation?—Altered neuronal Ca2+ handling in Huntington's disease
Mackay, J. P., Nassrallah, W. B., & Raymond, L. A. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12817 · Cited by 40
SUMOylation Prevents Huntingtin Fibrillization and Localization onto Lipid Membranes
Sedighi, F., Adegbuyiro, A., & Legleiter, J. A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00509 · Cited by 40

Authors: Panov, A. V., Gutekunst, C.-A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T.
Affiliations: Emory University (US)
University of British Columbia (CA)
Duke Medical Center (US)
Corresponding author: Greenamyre, J. Timothy
ORCID: Panov, Alexander V.
Gutekunst, Claire-Anne
Leavitt, Blair R.
Hayden, Michael R.
Burke, James R.
Greenamyre, J. Timothy
Venue: Nature Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2002-07-01
Volume: 5
Issue: 8
Pages: 731-736
ISSN: 1097-6256 (ISSN-L)
1546-1726
DOI: 10.1038/nn884
OpenAlex: W1972771185
Cited by: 1,030
References: 35
Citations by year: 2026: 16 · 2025: 23 · 2024: 26 · 2023: 27 · 2022: 30 · 2021: 49 · 2020: 29 · 2019: 35 · 2018: 39 · 2017: 23 · 2016: 45 · 2015: 35 · 2014: 48 · 2013: 33 · 2012: 68
FWCI: 19.24
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Neuroscience (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ag014648-05)
National Institute on Aging (AG14648)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Keywords: Huntington's disease, mitochondrial calcium handling, polyglutamine expansion, mutant huntingtin, mitochondrial membrane potential, mitochondrial depolarization, neurodegeneration, transgenic mice, early pathogenesis
MeSH terms: Huntingtin Protein, Animals, Brain, Brain Chemistry, Calcium, Cell Line, Disease Models, Animal, Humans, Huntington Disease, Intracellular Membranes, Lymphocytes, Membrane Potentials, Mice, Transgenic, Microscopy, Electron, Mitochondria, Nerve Tissue Proteins, Nuclear Proteins, Recombinant Fusion Proteins, Trinucleotide Repeat Expansion, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks